Clinical trials
Completed Phase 3 Uterine Cervical Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 4 |
| 2002 | 6 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 8 |
| 2008 | 6 |
| 2009 | 9 |
| 2010 | 3 |
| 2011 | 8 |
| 2012 | 4 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 93 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 19 |
| Merck Sharp & Dohme LLC | 14 |
| Gynecologic Oncology Group | 5 |
| M.D. Anderson Cancer Center | 3 |
| Tata Memorial Hospital | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| GOG Foundation | 2 |
| Radiation Therapy Oncology Group | 2 |
| Shanghai Bovax Biotechnology Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 93 |
| Papillomavirus Infections | 26 |
| Condylomata Acuminata | 14 |
| Vaginal Neoplasms | 12 |
| Vulvar Neoplasms | 12 |
| Endometrial Neoplasms | 9 |
| Neoplasms | 8 |
| Uterine Cervical Dysplasia | 8 |
| Breast Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
Trials
Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.